Journal Information
Vol. 98. Issue 2.
Pages 112-115 (March 2007)
Vol. 98. Issue 2.
Pages 112-115 (March 2007)
Case report
Full text access
Incontinentia Pigmenti: Three New Cases That Demonstrate it is not Only a Matter of Women
Incontinentia Pigmenti: Tres Nuevos Casos Que Demuestran Que no es Sólo Cosa de Mujeres
Visits
7193
M. Feito-Rodrígueza,
Corresponding author
marta8marta@hotmail.com

Correspondence: Servicio de Dermatología. Hospital Universitario La Paz. Paseo de la Castellana, 261. 28046 Madrid. Spain.
, J. García-Macarróna, E. Ruiz Bravo-Burguillosb, Á. Vera-Casañoc, R. de Lucas-Lagunaa
a Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain
b Servicio de Anatomía Patológica, Hospital Universitario La Paz, Madrid, Spain
c Servicio de Dermatología, Hospital Universitario Carlos Haya, Málaga, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Incontinentia pigmenti is a rare, dominantly X-linked genodermatosis characterized by multisystemic involvement that is lethal prenatally in the majority of affected males and shows great clinical variability when it is expressed in women. Recently it has been shown that mutations of the gene NEMO/IKK-g located in Xq28 cause the expression of the disease, being only one mutation responsible for approximately 80% of the cases. The diagnosis of incontinentia pigmenti is performed based on clinical features and family history with the support of histological findings. Nevertheless, as the gene responsible for the phenotype of the disease has been identified, a genetic study may be employed for doubtful cases. We report three cases of this entity (two women and one man) in different clinical stages of development that show the broad clinical spectrum we may encounter in the clinic.

Key words:
incontinentia pigmenti
hereditary bullous disease
Resumen

La incontinentia pigmenti es una genodermatosis infrecuente con carácter multisistémico que sigue un patrón de herencia dominante ligado a X, por lo que resulta letal en la mayoría de varones afectados intraútero y muestra gran variabilidad clínica cuando se expresa en mujeres. Recientemente se ha encontrado que las mutaciones del gen NEMO/IKK-γ localizado en Xq28 causan la expresión de la enfermedad, siendo una única mutación la responsable de aproximadamente un 80% de los casos. La incontinentia pigmenti interesa a varias especialidades médicas, aunque son la clínica cutánea y la historia familiar las que marcan el diagnóstico, ayudadas de los hallazgos histológicos. No obstante, la identificación reciente del gen responsable del fenotipo de la enfermedad permite la resolución de muchos casos dudosos mediante estudio genético.

Presentamos a continuación tres nuevos casos de esta patología (dos mujeres y un varón) en diferentes estadios evolutivos, que muestran el amplio espectro clínico con el que esta patología puede llegar a nuestra consulta.

Palabras clave:
incontinentia pigmenti
enfermedad ampollosa hereditaria
Full text is only aviable in PDF
References
[1.]
A.L. Berlin, A.S. Paller, L.S. Chan.
Incontinentia pigmenti: A review and update on the molecular basis of pathophysiology.
J Am Acad Dermatol, 47 (2002), pp. 169-187
[2.]
S. Hadj-Rabia, D. Froidevaux, N. Bodak, D. Hamel-Teillac, A. Smahi, Y. Touil, et al.
Clinical study of 40 cases of incontinentia pigmenti.
Arch Dermatol, 139 (2003), pp. 1163-1170
[3.]
T.A. Phan, O. Wargon, A.M. Turner.
Incontinentia pigmenti case series: clinical spectrum of incontinentia pigmenti in 53 female patients and their relatives.
Clin Exp Dermatol, 30 (2005), pp. 474-480
[4.]
The International Incontinentia Pigmenti (IP) Consortium.
Survival of male patients with Incontinentia Pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter Syndrome.
Am J Hum Genet, 69 (2001), pp. 1210-1217
[5.]
The International Incontinentia Pigmenti (IP) Consortium.
Genomic rearrangement in NEMO impairs NF-kB activation and is a cause of incontinentia pigmenti.
Nature, 405 (2000), pp. 466-472
[6.]
S. Mansour, H. Woffendin, S. Mitton, I. Jeffery, T. Jakins, S. Kenwrick, et al.
Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection.
Am J Med Genet, 99 (2001), pp. 172-177
[7.]
A.E. Scheuerle.
Male cases of incontinentia pigmenti: case report and review.
Am J Med Genet, 77 (1998), pp. 201-218
[8.]
R.G. Carney.
Incontinentia pigmenti: a world statistical analysis.
Arch Dermatol, 112 (1976), pp. 535-542
[9.]
S.J. Landy, D. Donnai.
Incontinentia pigmenti (Bloch-Sulzberger syndrome).
J Med Genet, 30 (1993), pp. 53-59
[10.]
Y.C. Chan, Y.C. Gima.
A retrospective study of incontinentia pigmenti seen at the National Skin Centre, Singapore over a 10-year period.
Ann Acad Med Singapore, 30 (2001), pp. 409-413
[11.]
D.A. Wiklund, W.L. Weston.
Incontinentia pigmenti. A fourgeneration study.
Arch Dermatol, 116 (1980), pp. 701-703
[12.]
A. Spallone.
Incontinentia pigmenti (Bloch-Sulzberger syndrome): seven case reports from one family.
Br J Ophthalmol, 71 (1987), pp. 629-634
[13.]
J.E. O’Brien, M. Feingold.
Incontinentia pigmenti. A longitudinal study.
Am J Dis Child, 139 (1985), pp. 711-712
[14.]
G. Holmström, K. Thorén.
Ocular manifestations of incontinentia pigmenti.
Acta Ophtalmol Scand, 78 (2000), pp. 348-353
[15.]
D. Weedon.
Disorders of pigmentation.
Skin Pathology, Churchill Livingstone, (2002),
Copyright © 2007. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Download PDF
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?